Literature DB >> 20956132

Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease.

K Sakamoto1, H Taniguchi, Y Kondoh, K Ono, Y Hasegawa, M Kitaichi.   

Abstract

The clinical course of patients with idiopathic pulmonary fibrosis (IPF) is generally marked by a decline in pulmonary function over time, although recently there is increasing recognition that fatal deterioration from acute exacerbation can occur at any stage. The patient described in the present case study was a 65-yr-old male who presented with exertional dyspnoea and fever of 2 weeks' duration. He had no history of chronic lung disease or physiological or radiological hallmarks of pre-existing disease. He underwent surgical lung biopsy and the histological examination showed a background pattern of usual interstitial pneumonia (UIP) with a pattern of focal acute diffuse alveolar damage (DAD) in the area where normal lung architecture was preserved. It is notable that the pathological diagnosis of this rapidly progressive interstitial pneumonia was DAD on UIP, which is typically seen in acute exacerbations of IPF. Unusual findings on high-resolution computed tomography scan were also noted. We presume that in this case acute exacerbation developed in the very early course of IPF. Given the possibility that similar cases may have arisen among patients diagnosed with acute interstitial pneumonia or acute respiratory distress syndrome, the histopathology of rapidly progressive interstitial pneumonia may need to be revisited.

Entities:  

Mesh:

Year:  2009        PMID: 20956132     DOI: 10.1183/09059180.00000409

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  7 in total

1.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

2.  Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges.

Authors:  Paolo Spagnolo; Roberto Tonelli; Elisabetta Cocconcelli; Alessandro Stefani; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2012-11-12

Review 3.  Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Konstantinos Kagouridis; Christina Triantafillidou; Iraklis Tsangaris; Charis Roussos
Journal:  Crit Care       Date:  2010-12-22       Impact factor: 9.097

Review 4.  Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.

Authors:  Fabrizio Luppi; Stefania Cerri; Sofia Taddei; Giovanni Ferrara; Vincent Cottin
Journal:  Intern Emerg Med       Date:  2015-02-12       Impact factor: 3.397

5.  COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.

Authors:  Yosuke Goto; Koji Sakamoto; Jun Fukihara; Atsushi Suzuki; Norihito Omote; Akira Ando; Yuichiro Shindo; Naozumi Hashimoto
Journal:  Front Med (Lausanne)       Date:  2022-02-03

6.  A case of asymptomatic, localized, and idiopathic diffuse alveolar damage.

Authors:  Young Do Jeon; H Christian Hong; Joon Sung Joh; Ja Young Jung; Ji Won Min; Seon Young Park; Ga Ram Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-04-30

Review 7.  Acute exacerbations in patients with idiopathic pulmonary fibrosis.

Authors:  Dong Soon Kim
Journal:  Respir Res       Date:  2013-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.